Call us on 0345 319 3000
Go to page:
Atorvastatin Shown to be Effective in Treating Macular
Phase I and II clinical trials have been conducted, at both the Massachusetts Eye and Ear/Harvard Medical School and the University of Crete, on the efficacy of certain cholesterol-lowering medication in the treatment of patients with dry macular degeneration.
Macular degeneration (AMD)... Read more
Trifocal lenses to help cataract surgery patients
One of the most common treatments of cataracts is the insertion of lens implants.
Using Gene Therapy to Restore Eye Sight to the Blind
RetroSense Therapeutics in Ann Arbor, Michigan are pioneering a method of genetic manipulation that could give back sight to people affected by retinal degenerative conditions, including retinitis pigmentosa (RP) and dry macular degeneration (AMD).
Photoreceptors in the back of our eyes,... Read more
Experts find night blindness gene
Specialists in the US have found a new type of genetic mutation responsible for deafness and hearing loss associated with Usher syndrome type 1, a defect that causes night-blindness and a loss of peripheral vision through the progressive degeneration of the retina.
Stem cells "boost visual function"
The elimination of eye diseases has taken a step closer after experts in the US reported that an experimental treatment for blindness was a success. The therapy, developed from a patient's skin cells, was seen to improve the vision of blind mice in a study conducted by Columbia University... Read more
Kaposi sarcoma findings could lead to AMD treatment
New scientific findings related to a rare cancer could pave the way for new treatments to be developed for age-related macular degeneration, one of the world's leading causes of sight loss, it has been suggested.
Statins "reduce glaucoma risk"
Patients who take statins to limit their risk of cardiovascular disease are also less likely to be diagnosed with glaucoma, the most common form of a leading cause of sight loss, it has been claimed.
A health warning regarding two counterfeit eye drops
The Health Services Authority in Singapore has issued a warning regarding two counterfeit eye drops, under the names EYE MO, and EYE MO Moist. The drops were determined to be of very poor quality, and showed evidence of bacterial contamination.
Microsoft is working on a virtual reality product called Hololens.
One of the most exciting developments in networked technology, is augmented reality.
High Tech Contact Lenses for Glaucoma Patients
After a glaucoma diagnosis, it's challenging to determine the rate at which the disease will progress. In some patient it develops slowly, where in others it advances very quickly. In either scenario, vision loss is an eventuality; the only question is how soon. A new, highly advanced
Go to page: